Ange Postecoglou will be quite pleased with his side’s performance and the scoring chances created, but the result leaves Tottenham Hotspur with a world of work still to do in the second leg after ...

Inter Milan's last-gasp 2-1 victory at Bayern Munich in the first leg of their Champions League quarte-final on Tuesday was the result of the Italian team's strong mentality but more work awaits ...

In October, Detroit Lions star Aidan Hutchinson suffered a serious season-ending leg injury. But just six months after fracturing his tibia and fibula, the edge rusher is back on the field.

A hillwalker was airlifted to hospital after suffering a horror leg injury on Arran. Arran Mountain Rescue Team were alerted to the incident on the island at the A'Chir ridge on Saturday ...

Halozyme Therapeutics (HALO) announced that Janssen-Cilag International NV, a Johnson & Johnson (JNJ) company, has received European Commission marketing authorization of the subcutaneous ...

Welcome to Sportstar’s highlights of the Indian Super League 2024-25 semifinal second leg match between FC Goa and Bengaluru FC played at the Fatorda Stadium on Sunday. There is a popular notion in ...

In December 2024, the Food and Drug Administration (FDA) approved the PD-1 inhibitor nivolumab (Opvido Qvantig) for use as a subcutaneous injection. Read on to learn more about this new approach ...

After a week’s worth of teasing, Wet Leg are officially back and have announced the follow-up to their 2022 self-titled debut. This one is titled moisturizer and it will be out July 11 via ...

Ultra-long-acting subcutaneous (SQ) injection formulation of small molecule ASC30 demonstrated a 36-day half-life in patients with obesity, supporting once monthly or less frequent administration. -As ...

A man in his 30s has overdosed in the "using space" – a room in the Glasgow facility where nurses supervise injections in eight booths. He had only arrived at The Thistle minutes earlier ...

Princeton: Bristol Myers Squibb has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has recommended approval of a new Opdivo (nivolumab) ...